Cargando…

Recent advances in ZBP1-derived PANoptosis against viral infections

Innate immunity is an important first line of defense against pathogens, including viruses. These pathogen- and damage-associated molecular patterns (PAMPs and DAMPs, respectively), resulting in the induction of inflammatory cell death, are detected by specific innate immune sensors. Recently, Z-DNA...

Descripción completa

Detalles Bibliográficos
Autores principales: Oh, SuHyeon, Lee, SangJoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10228733/
https://www.ncbi.nlm.nih.gov/pubmed/37261341
http://dx.doi.org/10.3389/fimmu.2023.1148727
_version_ 1785051035001159680
author Oh, SuHyeon
Lee, SangJoon
author_facet Oh, SuHyeon
Lee, SangJoon
author_sort Oh, SuHyeon
collection PubMed
description Innate immunity is an important first line of defense against pathogens, including viruses. These pathogen- and damage-associated molecular patterns (PAMPs and DAMPs, respectively), resulting in the induction of inflammatory cell death, are detected by specific innate immune sensors. Recently, Z-DNA binding protein 1 (ZBP1), also called the DNA-dependent activator of IFN regulatory factor (DAI) or DLM1, is reported to regulate inflammatory cell death as a central mediator during viral infection. ZBP1 is an interferon (IFN)-inducible gene that contains two Z-form nucleic acid-binding domains (Zα1 and Zα2) in the N-terminus and two receptor-interacting protein homotypic interaction motifs (RHIM1 and RHIM2) in the middle, which interact with other proteins with the RHIM domain. By sensing the entry of viral RNA, ZBP1 induces PANoptosis, which protects host cells against viral infections, such as influenza A virus (IAV) and herpes simplex virus (HSV1). However, some viruses, particularly coronaviruses (CoVs), induce PANoptosis to hyperactivate the immune system, leading to cytokine storm, organ failure, tissue damage, and even death. In this review, we discuss the molecular mechanism of ZBP1-derived PANoptosis and pro-inflammatory cytokines that influence the double-edged sword of results in the host cell. Understanding the ZBP1-derived PANoptosis mechanism may be critical for improving therapeutic strategies.
format Online
Article
Text
id pubmed-10228733
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-102287332023-05-31 Recent advances in ZBP1-derived PANoptosis against viral infections Oh, SuHyeon Lee, SangJoon Front Immunol Immunology Innate immunity is an important first line of defense against pathogens, including viruses. These pathogen- and damage-associated molecular patterns (PAMPs and DAMPs, respectively), resulting in the induction of inflammatory cell death, are detected by specific innate immune sensors. Recently, Z-DNA binding protein 1 (ZBP1), also called the DNA-dependent activator of IFN regulatory factor (DAI) or DLM1, is reported to regulate inflammatory cell death as a central mediator during viral infection. ZBP1 is an interferon (IFN)-inducible gene that contains two Z-form nucleic acid-binding domains (Zα1 and Zα2) in the N-terminus and two receptor-interacting protein homotypic interaction motifs (RHIM1 and RHIM2) in the middle, which interact with other proteins with the RHIM domain. By sensing the entry of viral RNA, ZBP1 induces PANoptosis, which protects host cells against viral infections, such as influenza A virus (IAV) and herpes simplex virus (HSV1). However, some viruses, particularly coronaviruses (CoVs), induce PANoptosis to hyperactivate the immune system, leading to cytokine storm, organ failure, tissue damage, and even death. In this review, we discuss the molecular mechanism of ZBP1-derived PANoptosis and pro-inflammatory cytokines that influence the double-edged sword of results in the host cell. Understanding the ZBP1-derived PANoptosis mechanism may be critical for improving therapeutic strategies. Frontiers Media S.A. 2023-05-16 /pmc/articles/PMC10228733/ /pubmed/37261341 http://dx.doi.org/10.3389/fimmu.2023.1148727 Text en Copyright © 2023 Oh and Lee https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Oh, SuHyeon
Lee, SangJoon
Recent advances in ZBP1-derived PANoptosis against viral infections
title Recent advances in ZBP1-derived PANoptosis against viral infections
title_full Recent advances in ZBP1-derived PANoptosis against viral infections
title_fullStr Recent advances in ZBP1-derived PANoptosis against viral infections
title_full_unstemmed Recent advances in ZBP1-derived PANoptosis against viral infections
title_short Recent advances in ZBP1-derived PANoptosis against viral infections
title_sort recent advances in zbp1-derived panoptosis against viral infections
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10228733/
https://www.ncbi.nlm.nih.gov/pubmed/37261341
http://dx.doi.org/10.3389/fimmu.2023.1148727
work_keys_str_mv AT ohsuhyeon recentadvancesinzbp1derivedpanoptosisagainstviralinfections
AT leesangjoon recentadvancesinzbp1derivedpanoptosisagainstviralinfections